Search research articles
Contact Us
Filters
Showing results (161-170 of 318) with videos related to
Page
of 32
Sort By:
Nanomedicine (London, England)
|
August 29, 2025
Cyclodextrin-AmB-IL-10 antagonist peptide nanoparticles treat leishmaniasis more effectively than conventional AmB
Ashish Kumar, Ritesh Tiwari, Shobha Kumari, et al.
Materials Science & Engineering. C, Materials for Biological Applications
|
December 15, 2015
Development of PLGA-PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis
Rishikesh Kumar, Ganesh Chandra Sahoo, Krishna Pandey, et al.
Plos Neglected Tropical Diseases
|
November 5, 2010
Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal
Diwakar Singh Dinesh, Murari Lal Das, Albert Picado, et al.
Pathogens and Global Health
|
April 15, 2016
Repeated training of accredited social health activists (ASHAs) for improved detection of visceral leishmaniasis cases in Bihar, India
Vidya Nand Ravi Das, Ravindra Nath Pandey, Vijay Kumar, et al.
International Journal of Bioinformatics Research and Applications
|
May 6, 2014
Structure, evolution and virtual screening of NDM-1 strain from Kolkata
Ganesh Chandra Sahoo, Mukta Rani, Yousuf Ansari, et al.
Parasites & Vectors
|
August 9, 2024
Knockdown resistance mutations in Phlebotomus argentipes sand flies in Bihar, India
Mojca Kristan, Carlamarita Hazelgrove, Kundan Kumar, et al.
Redox Biology
|
March 14, 2017
Deciphering the interplay between cysteine synthase and thiol cascade proteins in modulating Amphotericin B resistance and survival of Leishmania donovani under oxidative stress
Kuljit Singh, Vahab Ali, Krishn Pratap Singh, et al.
Molecular Immunology
|
October 1, 2023
Adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides protection against wild-type parasites
Rajan Singh, Anshul Anand, Baishakhi Mahapatra, et al.
Plos One
|
May 18, 2016
Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients
Vijayamahantesh, Ajay Amit, Manas R Dikhit, et al.
Antimicrobial Agents and Chemotherapy
|
May 3, 2017
<i>In Vitro</i> Evaluation of Antileishmanial Activity of Computationally Screened Compounds against Ascorbate Peroxidase To Combat Amphotericin B Drug Resistance
Rani Mansuri, Ashish Kumar, Sindhuprava Rana, et al.
Page
of 32
Search research articles
Search
Showing results (161-170 of 318) with videos related to
Sort By:
Page
of 32
Nanomedicine (London, England)
|
August 29, 2025
Cyclodextrin-AmB-IL-10 antagonist peptide nanoparticles treat leishmaniasis more effectively than conventional AmB
Ashish Kumar, Ritesh Tiwari, Shobha Kumari, et al.
Materials Science & Engineering. C, Materials for Biological Applications
|
December 15, 2015
Development of PLGA-PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis
Rishikesh Kumar, Ganesh Chandra Sahoo, Krishna Pandey, et al.
Plos Neglected Tropical Diseases
|
November 5, 2010
Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal
Diwakar Singh Dinesh, Murari Lal Das, Albert Picado, et al.
Pathogens and Global Health
|
April 15, 2016
Repeated training of accredited social health activists (ASHAs) for improved detection of visceral leishmaniasis cases in Bihar, India
Vidya Nand Ravi Das, Ravindra Nath Pandey, Vijay Kumar, et al.
International Journal of Bioinformatics Research and Applications
|
May 6, 2014
Structure, evolution and virtual screening of NDM-1 strain from Kolkata
Ganesh Chandra Sahoo, Mukta Rani, Yousuf Ansari, et al.
Parasites & Vectors
|
August 9, 2024
Knockdown resistance mutations in Phlebotomus argentipes sand flies in Bihar, India
Mojca Kristan, Carlamarita Hazelgrove, Kundan Kumar, et al.
Redox Biology
|
March 14, 2017
Deciphering the interplay between cysteine synthase and thiol cascade proteins in modulating Amphotericin B resistance and survival of Leishmania donovani under oxidative stress
Kuljit Singh, Vahab Ali, Krishn Pratap Singh, et al.
Molecular Immunology
|
October 1, 2023
Adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides protection against wild-type parasites
Rajan Singh, Anshul Anand, Baishakhi Mahapatra, et al.
Plos One
|
May 18, 2016
Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients
Vijayamahantesh, Ajay Amit, Manas R Dikhit, et al.
Antimicrobial Agents and Chemotherapy
|
May 3, 2017
<i>In Vitro</i> Evaluation of Antileishmanial Activity of Computationally Screened Compounds against Ascorbate Peroxidase To Combat Amphotericin B Drug Resistance
Rani Mansuri, Ashish Kumar, Sindhuprava Rana, et al.
Page
of 32